Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Receivables (2022 - 2025)

HeartSciences' Receivables history spans 4 years, with the latest figure at $4350.0 for Q2 2025.

  • For Q2 2025, Receivables changed N/A year-over-year to $4350.0; the TTM value through Apr 2025 reached $4350.0, changed N/A, while the annual FY2025 figure was $4350.0, N/A changed from the prior year.
  • Receivables reached $4350.0 in Q2 2025 per HSCS's latest filing, down from $14700.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $14700.0 in Q1 2024 to a low of $2321.0 in Q2 2022.
  • Average Receivables over 4 years is $6317.8, with a median of $4125.0 recorded in 2023.